Case of metastatic kaposi sarcoma successfully treated with anti-PD-1 immunotherapy.

E Cesmeci Deniz Can GuvenB Y AktasS Aksoy

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)

ICI on KS is still a blurred option to be included in standard regimens; but progressive understanding of PD-1 expression and its role in disease progression may be a milestone for further treatment algorithms on KS. Besides good efficacy, tolerability of ICIs could be helpful patients with comorbidities precluding the use of chemotherapy.

Keyphrases

poor prognosis
machine learning
squamous cell carcinoma
small cell lung cancer
multiple sclerosis
open label
locally advanced
deep learning
randomized controlled trial
binding protein
placebo controlled
double blind
study protocol